Navigation Links
Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
Date:4/22/2008

- Completion of enrollment in second Phase 3 trial expected by end of

summer -

- First Phase 3 data now expected by mid-2009, with all Phase 3 data

expected in fall 2009 -

ROCKVILLE, Md., April 22 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has completed enrollment and initial dosing in BLISS-52, one of two pivotal Phase 3 clinical trials of LymphoStat-B(R) (belimumab) in patients with active systemic lupus erythematosus (SLE). LymphoStat-B is being developed by HGS and GlaxoSmithKline (GSK) under a co-development and commercialization agreement entered into in August 2006.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

"We continue to be excited by LymphoStat-B's potential. Assuming it is successful in Phase 3, we believe that LymphoStat-B could represent a breakthrough in the treatment of SLE," said H. Thomas Watkins, President and Chief Executive Officer, HGS. "With enrollment now completed in the BLISS-52 trial, we are on track to have our first Phase 3 data for LymphoStat-B available by mid-2009, and all Phase 3 data available in fall 2009."

BLISS-52 was initiated in May 2007, and has enrolled and randomized a total of 867 patients at 90 clinical sites in 13 countries, primarily in Asia, South America and Eastern Europe. Completion of enrollment for the other pivotal Phase 3 trial of belimumab, BLISS-76, is expected by the end of summer 2008. BLISS-76, which was initiated in February 2007, is being conducted primarily in North America and Europe, and will enroll and randomize a minimum of 810 sub
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
2. Data Show SuperGens MP-470 is Safe in Humans
3. Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
4. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
5. Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
6. ExonHits EHT 0202 Counters Scopolamines Detrimental Effects on Cognition in Humans
7. Valor Medical Announces First Human Implant of Neucrylate AN(TM) for Treatment of Cerebral Aneurysm
8. Synbiotics Corporation Announces Human Submission for FluDetect(R)
9. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
10. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
11. N30 Pharma Announces Successful Initiation of Human Studies With N30-201
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... SAN FRANCISCO , April 21, 2015   ... focusing on the advancement of cardiac care, announced today ... care systems in the U.S., will now be offering ... of long-term continuous cardiac monitoring. "At Banner ... by improving patient outcomes and services," said John ...
(Date:4/21/2015)... , April 21, 2015  Decision Diagnostics Corp. ... and the exclusive worldwide sales, service and regulatory ... FDA-cleared Green Alternative Strip, specifically designed to work ... OneTouch Ultra family of glucose testing meters, the ... today that Johnson & Johnson/Lifescan has requested an ...
(Date:4/21/2015)... , April 21, 2015  CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today ... on Tuesday, April 28, 2015.  On that day, the ... at 10:00 a.m. Eastern Time to discuss the results, ... Pat Mackin , Chairman, President and Chief Executive ...
Breaking Medicine Technology:Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 2Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 3Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 2Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 3CryoLife Announces Release Date and Teleconference Call Details for 2015 First Quarter Financial Results 2
... -- Chindex International, Inc. (NASDAQ: ... care services in China through the operations of United ... and affiliated ambulatory clinics, today announced that the Company ... and first half of 2011, which ended June 30, ...
... Apnex Medical, Inc., received investigational device exemption (IDE) approval ... begin a clinical study to evaluate the safety and ... treat obstructive sleep apnea (OSA). Data from this clinical ... application for the HGNS System to the FDA. ...
Cached Medicine Technology:Chindex International, Inc. to Report Financial Results for the Second Quarter and First Half of 2011 2Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea 2Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea 3
(Date:4/21/2015)... 2015 Angelo’s FabriClean has recently announced ... for clients that avail the area rug cleaning services. ... done with hi-tech equipments, making use of the quick ... all natural, high pressure steam extraction to clean even ... for area rugs made with delicate fabric. , ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Catalent ... delivery technologies and development solutions for drugs, biologics ... of ADVASEPT™ Lock, a stopper-less, glass- and needle-free ... injectable medications. Easily opened, ADVASEPT Lock attaches to ... functional container closure with the security of an ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 QuickMedical, ... equipment and supplies, now represents Schiller America's ... Monitors, ECGs, Stress Tests, and Vital Signs Monitors, ... in Switzerland, is a global leader in the ... products are developed in close cooperation with the ...
(Date:4/21/2015)... The 2015 Market Research Report ... professional and in-depth study on the current state ... with a focus on the Chinese situation. ... market research are Cargill, Fbc Industries, Posy Pharmachem, ... Capchem, Lianyungang Mupro Fi, Yixing-Union, Debang Fine Chemical, ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Further strengthening ... committed $1.2 million in donated goods and services to ... care through the USF Health BRIDGE Healthcare Clinic. , ... community clinic in its eighth year – provides primary ... year one night a week inside the USF Health ...
Breaking Medicine News(10 mins):Health News:Angelo’s FabriClean Now Offers Area Rug Cleaning in South Surrey with Complimentary Pick-Up and Delivery 2Health News:Catalent Announces the Expansion of its Advanced, Aseptic, Glass-Free Injectable Platform with New ADVASEPT™ Lock Delivery Technology 2Health News:QuickMedical Launches New Product Line: Schiller America 2Health News:QuickMedical Launches New Product Line: Schiller America 3Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 3Health News:USF Health and Florida Hospital Tampa Partner to Expand BRIDGE Clinic 2Health News:USF Health and Florida Hospital Tampa Partner to Expand BRIDGE Clinic 3
... VIEJO, Calif., Feb. 25 The Ensign,Group, ... company of the Ensign(TM) group of,skilled nursing, ... that GE Healthcare Financial Services has expanded,Ensign,s ... it an,additional five years., (Logo: ...
... WASHINGTON, Feb. 25 House Republican Whip,Roy Blunt ... legislation that will be introduced by Republican Leader ... in an effort to put,Medicare on a path ... sorely needed reforms to put,Medicare on a path ...
... for Medicare Advantage,Plans Sold to Senior Citizens, ... today that it will require UnitedHealth Group Inc.,(United) ... assets relating,to United,s Medicare Advantage business in the ... acquisition of Sierra. The Department said that the,transaction, ...
... L. Mitchell, M.D., M.P.H., of Hebrew SeniorLifes Institute ... with advanced dementia are frequently prescribed antibiotic medications, ... practice raises concerns about the end-of-life care of ... as the emergence of antimicrobial resistance. The paper ...
... place burden on Medicare, analysis finds , , MONDAY, Feb. ... Americans newly diagnosed with heart failure has declined, the ... new research finds. , The Duke University study analyzed ... diagnosed with heart failure between 1994 and 2003. It ...
... to increase the risk that women will have abnormal ... effectiveness of both methods for detecting breast cancer, according ... Archives of Internal Medicine, one of the JAMA/Archives journals. ... at the Los Angeles Biomedical Research Institute at Harbor-UCLA ...
Cached Medicine News:Health News:The Ensign Group Establishes $50 Million Credit Facility with GE Healthcare Financial Services 2Health News:Justice Department Requires Divestiture in UnitedHealth Group's Acquisition of Sierra Health Services 2Health News:Justice Department Requires Divestiture in UnitedHealth Group's Acquisition of Sierra Health Services 3Health News:Hebrew SeniorLife researcher finds 2Health News:Hebrew SeniorLife researcher finds 3Health News:More Elderly Americans Living With Heart Failure 2Health News:LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies 2